Joseph Uberti

基本信息

Career Trajectory

Bio

Dr. Joseph Uberti is an oncologist in Detroit, MI and is affiliated with multiple hospitals in the area, including Karmanos Cancer Center, DMC - Detroit Receiving Hospital, and DMC Harper University Hospital. He received his medical degree from Wayne State University School of Medicine and has been in practice 34 years. He specializes in hematologic oncology and is experienced in bone marrow transplantation, multiple myeloma, lymphoma, myeloproliferative disease, and leukemia.

Research Interests

Papers共 172 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704

Mohamed L Sorror,Wael Saber,Brent R Logan, Nancy L Geller, Anna Bellach, Jianqun Kou,William A Wood,John McCarty,Thomas G Knight,Lyndsey Runaas, Laura J Johnston,Jeremy D Walston,Ryotaro Nakamura, Lori Jarrett,Asmita Mishra,Joseph Uberti,Parastoo B Dahi,Jennifer N Saultz,Shannon R McCurdy,Lawrence E Morris, Philip Imus,William J Hogan, Kalyan V G Nadiminti, Vijaya R Bhatt,Rebecca L Olin,Joseph Maakaron, Ronald M Sobecks,Sarah A Wall, Deborah Mattila, Bailey Protz,Steven M Devine,Mary M Horowitz,Andrew S Artz

Blood advances (2025)

Cited0Views0WOSBibtex

Prognostic Understanding for Older, Medically Infirm, And/or Frail Recipients of Allogeneic Hematopoietic Cell Transplantation in an Ongoing Seamless Phase 2/3 Randomized Interventional Trial (ACE-BMT)

Elizabeth T. Loggers,James Fausto, Matthew Givens,Mei-Ean Yeow,Reena Jayani,Hassan B. Alkhateeb,Laura A. Schoenherr,Michael W. Rabow,Mark B. Juckett,George Carrum,Joseph Uberti,Kyle Neale, Santiago Lopez, Diana Martins-Welch, Jeanette G. Ferrer, Laura S. Rhee,Drew A. Rosielle,Susan Mcinnes,Jason A. Webb,Rachel J. Cook, Elisheva Newman,Ronald Sobecks,Laura Johnston,Mohamed Sorror

BLOOD (2024): 2297-2298

Cited0Views0Bibtex

Abstract CT151: Trial in Progress:A Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Eliminate Residual Disease after Hematopoietic Cell Transplantation

Monzr M. Al Malki,Alla Keyzner,Hyung Chan Suh,Uday Popat,Yibin Chen,Saar Gill,Melhem Solh,Joseph P. Uberti,Iris Isufi, Erica L. Buonomo, Yun Wang,J. A. H. Murray,Gavin MacBeath,Débora Barton,Shrikanta Chattopadhyay,Ran Reshef

Cancer Researchno. 7_Supplement (2024): CT151-CT151

Cited0Views0Bibtex

Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: an Interventional Trial

medRxiv the preprint server for health sciences (2024)

Cited0Views0WOSBibtex

False-Positive Human Immunodeficiency Virus Nucleic Acid Amplification Test after Chimeric Antigen Receptor T-Cell Therapy with Ciltacabtagene Autoleucel

Vishakh C. Keri, Mary Vito Topulli,Abhinav Deol,Joseph Uberti,Hossein Salimnia,Pranatharthi H. Chandrasekar

OPEN FORUM INFECTIOUS DISEASESno. 1 (2024)

Cited1Views0WOSBibtex

Trial in Progress: A Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Eliminate Residual Disease after Hematopoietic Cell Transplantation

Monzr Al Malki,Alla Keyzner,Hyung Suh,Uday Popat,Saar Gill,Yi-Bin Chen,Melhelm Solh,Joseph Uberti,Lohith Gowda,Erica Buonomo, Yun Wang,Jim Murray,Gavin MacBeath,Debora Barton,Shrikanta Chattopadhyay,Ran Reshef

MOLECULAR THERAPYno. 4 (2024): 884-885

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 172 篇Author StatisticsCo-AuthorSimilar Experts